Peroxiredoxin 5 Protects TGF-β Induced Fibrosis by Inhibiting Stat3 Activation in Rat Kidney Interstitial Fibroblast Cells

Abstract

Renal fibrosis is a common final pathway of end-stage kidney disease which is induced by aberrant accumulation of myofibroblasts. This process is triggered by reactive oxygen species (ROS) and proinflammatory cytokines generated by various source of injured kidney cells. Peroxiredoxin 5 (Prdx5) is a thiol-dependent peroxidase that reduces oxidative stress by catalyzing intramolecular disulfide bonds. Along with its antioxidant effects, expression level of Prdx5 also was involved in inflammatory regulation by immune stimuli. However, the physiological effects and the underlying mechanisms of Prdx5 in renal fibrosis have not been fully characterized. Sprague-Dawley rats were subjected to unilateral ureteral obstruction (UUO) for 1 or 7 days. For the in vitro model, NRK49F cells, a rat kidney interstitial fibroblast cell lines, were treated with transforming growth factor β (TGF-β) for 0, 1, 3, or 5 days. To access the involvement of its peroxidase activity in TGF-β induced renal fibrosis, wild type Prdx5 (WT) and double mutant Prdx5 (DM), converted two active site cysteines at Cys 48 and Cys 152 residue to serine, were transiently expressed in NRK49F cells. The protein expression of Prdx5 was reduced in UUO kidneys. Upregulation of fibrotic markers, such as fibronectin and alpha-smooth muscle actin (α-SMA), declined at 5 days in time point of higher Prdx5 expression in TGF-β treated NRK49F cells. The overexpression of wild type Prdx5 by transient transfection in NRK49F cells attenuated the TGF-β induced upregulation of fibronectin and α-SMA. On the other hand, the transient transfection of double mutant Prdx5 did not prevent the activation of fibrotic markers. Overexpression of Prdx5 also suppressed the TGF-β induced upregulation of Stat3 phosphorylation, while phosphorylation of Smad 2/3 was unchanged. In conclusion, Prdx5 protects TGF-β induced fibrosis in NRK49F cells by modulating Stat3 activation in a peroxidase activity dependent manner.

NEAT1 paraspeckle promotes human hepatocellular carcinoma progression by strengthening IL-6/STAT3 signaling

“…Furthermore, dysregulation of lncRNAs which contributes to overexpression of pro-inflammatory cytokines and overactivation of pro-inflammatory pathways are also largely implicated in the pathogenesis of inflammatory diseases, including cancers. 38 Revealing more inflammationrelated lncRNAs and their function, especially for maintaining chronic inflammation will be helpful for unveiling the pathogenic mechanisms of inflammatory disease. lncRNA -NEAT1 has been found to promote HCC by sponging microRNA, modulating abnormal lipolysis or affecting the epithelialmesenchymal transition.…”

Metformin attenuates renal fibrosis in both AMPKα2‐dependent and independent manners

“…1 Furthermore, we found that metformin targets the TGFβ1 downstream signalling pathway by directly interacting with TGFβ1 in an AMPK-independent manner. 26 Additionally, previous studies showed that metformin suppressed signal transducer and activator of transcription 3 (STAT3) activation, thereby decreasing the expression of multiple profibrotic genes in the kidney 28,29 via the AMPK-independent pathway. 27 Second, the protective effects observed in AMPKa2 −/− mice may be due to AMPKα1 activation.…”

Endostatin inhibits fibrosis by modulating the PDGFR/ERK signal pathway: an in vitro study

“…As a subtype of PDGF, PDGF-BB has a strong mitogenic effect on fibroblasts (Lin et al, 2015). TGF-β and PDGF-BB have usually been employed as the fibrosis models in previous studies for their fibrosis-promoting effect (Cho et al, 2016;Choi et al, 2016). The PDGF receptor (PDGFR) signal pathway is involved in both angiogenesis and fibrosis and has become a new target for treating fibrosis.…”